Detalhe da pesquisa
1.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
N Engl J Med
; 387(16): 1445-1455, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260792
2.
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo.
J Allergy Clin Immunol
; 153(1): 161-172.e8, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777018
3.
Stigma in vitiligo: associated factors and severity strata of the Patient Unique Stigmatization Holistic tool in Dermatology (PUSH-D) score.
Br J Dermatol
; 190(5): 712-717, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38234050
4.
A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
Br J Dermatol
; 190(2): 216-225, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877514
5.
Facial involvement is reflective of patients' global perception of vitiligo extent.
Br J Dermatol
; 189(2): 188-194, 2023 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37002778
6.
Has the core outcome (domain) set for vitiligo been implemented? An updated systematic review on outcomes and outcome measures in vitiligo randomized clinical trials.
Br J Dermatol
; 188(2): 247-258, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763863
7.
Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study.
Br J Dermatol
; 189(5): 569-577, 2023 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493275
8.
Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithm.
Br J Dermatol
; 190(1): 62-69, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615581
9.
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial.
J Am Acad Dermatol
; 88(2): 395-403, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370907
10.
Prevalence of Vitiligo among Children and Adolescents in the United States.
Dermatology
; 239(2): 227-234, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630928
11.
Association of Chronic Urticaria with Psychological Distress: A Multicentre Cross-sectional Study.
Acta Derm Venereol
; 103: adv00865, 2023 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36129251
12.
Impact of Atopic Dermatitis on Patients and their Partners.
Acta Derm Venereol
; 103: adv5285, 2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358393
13.
Use of multiple correspondence analysis to explore associations between caregivers and sun protective habits during summer vacations.
Clin Exp Dermatol
; 49(1): 26-34, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539734
14.
Patient Unique Stigmatization Holistic tool in dermatology (PUSH-D): Development and validation of a dermatology-specific stigmatization assessment tool.
J Eur Acad Dermatol Venereol
; 37(2): 443-450, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201355
15.
Vitiligo patient population and disease burden in France: VIOLIN study results from the CONSTANCES cohort.
J Eur Acad Dermatol Venereol
; 37(11): 2249-2258, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605309
16.
Clinician-reported outcome measures for the assessment of vitiligo: A scoping review.
J Eur Acad Dermatol Venereol
; 37(11): 2231-2242, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602494
17.
Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts.
J Eur Acad Dermatol Venereol
; 37(1): 21-31, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259656
18.
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.
J Eur Acad Dermatol Venereol
; 37(11): 2173-2184, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746876
19.
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations.
J Eur Acad Dermatol Venereol
; 37(11): 2185-2195, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715487
20.
Patient Perception of the Diagnosis Announcement and its Impact on Quality of Life of Patients with Primary Melanoma or Basal Cell Carcinoma.
Acta Derm Venereol
; 102: adv00717, 2022 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470404